ARTICLE | Company News
Cornerstone Therapeutics, Digestive Care sales and marketing update
May 13, 2013 7:00 AM UTC
Digestive Care granted Cornerstone exclusive, U.S. rights to market Pertzye pancrelipase for 10 years to treat exocrine pancreatic insufficiency due to cystic fibrosis (CF). Digestive Care will recei...